Results 191 to 200 of about 130,790 (247)

TNF‐α partially modulates the endothelial dysfunction during the acute phase of Trypanosoma cruzi infection

British Journal of Pharmacology, Volume 183, Issue 10, Page 2256-2272, May 2026.
Background and Purpose Whereas the effects of Trypanosoma cruzi (T. cruzi) infection are well‐characterised in the heart, its impact on the vasculature has received little attention. In this study, we investigated the effects of acute and chronic T. cruzi infection on vascular responsiveness and the underlying mechanisms.
Thales M. H. Dourado, Wanessa M. C. Awata, Gustavo F. Pimenta, Barbara M. Marchetti, Maiara V. Providello, Sérgio De Albuquerque, Carlos R. Tirapelli   +6 more
wiley   +1 more source

Concurrent Nivolumab-Induced Myocarditis and Myasthenia Gravis: A Case Report. [PDF]

Case Rep Oncol Med
Gupta R, Plumber N, Lee J, Sivasubramanian BP, Kyhan ME, Singh H, Gupta S.   +6 more
europepmc   +1 more source

The relationship between the cannabinoids and cardiac remodelling: A comprehensive review of pivotal mechanisms and emerging evidence

British Journal of Pharmacology, Volume 183, Issue 9, Page 1747-1778, May 2026.
Cardiac remodelling and fibrosis after myocardial infarction or during chronic diseases, such as arterial and pulmonary hypertension or diabetes mellitus, continue to be the more important prognostic factors in determining survival, and so the search for effective anti‐fibrotic interventions is an important target for research and therapy in cardiology.
Anna Krzyżewska, Marta Baranowska‐Kuczko, Hanna Kozłowska   +2 more
wiley   +1 more source

Heart-Brain Axis in Viral Myocarditis: Shared Cytokine Pathways, Blood-Brain Barrier Crosstalk, and Neuroinflammatory Consequences. [PDF]

Int J Mol Sci
Mitrokhin VM, Kamkin AG, Babkina II, Savinkova IG, Shileiko SA, Ovchinnikov RS, Mladenov MI.   +6 more
europepmc   +1 more source

Bispecific Dual‐Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients

Journal of Cutaneous Pathology, Volume 53, Issue 5, Page 422-426, May 2026.
ABSTRACT Lorigerlimab is a dual bispecific antibody (BsAb) targeting cytotoxic T‐lymphocyte‐associated protein 4 and programmed cell death protein 1 that is used for treatment of advanced solid cancers such as metastatic castration‐resistant prostate carcinoma.
Niloofar Sina, Fiorinda Muhaj, Volha Lenskaya, Doina Ivan, Victor G. Prieto, Jonathan L. Curry   +5 more
wiley   +1 more source

Case Report: Successful treatment of steroid-refractory immune checkpoint inhibitor associated myocarditis with tofacitinib. [PDF]

Front Immunol
Kong D, Zhang F, Liu Y, Zhu X, Yuan T, Liu A, Zhou L, Chen W, Yao Q.   +8 more
europepmc   +1 more source

Management and Prognosis of Patients With Acute Pericarditis in the Emergency Department: A Retrospective, Single‐Centre Study

European Journal of Clinical Investigation, Volume 56, Issue 5, May 2026.
In this retrospective, single‐centre study conducted in patients with acute pericarditis referred to the Emergency Department, a significant proportion of patients experienced long‐term complications, especially recurrences. Drug doses were compliant with guidelines in a limited number of patients at admission and increased at discharge. Diabetes, COPD,
Lisa Caldera, Chiara Lovati, Alessandra Vecchié, Walter Ageno, Marco Paolo Donadini, Francesco Dentali, Flavio Tangianu, Aldo Bonaventura   +7 more
wiley   +1 more source

Acute Myocarditis Initially Presenting as Inflammatory Gastroenteritis With a Delayed Onset of Typical Chest Pain: A Diagnostic Challenge. [PDF]

Cureus
Elzoheiry E, Abdow M, Al Ahmar A.
europepmc   +1 more source

T Cell Receptor Repertoires Across the Continuum of Vascular, Myocardial, and Age‐Related Diseases

Immunological Reviews, Volume 339, Issue 1, May 2026.
ABSTRACT Cardiovascular diseases (CVD) are shaped by a complex interplay with immune mechanisms. In particular, the distinct roles of antigen‐specific T cell mechanisms are emerging as critical determinants across a broad spectrum of conditions, ranging from atherosclerosis, myocardial infarction (MI), heart failure (HF), and myocarditis. Because these
Leon Richter, João Dias‐Ferreira, Gustavo Campos Ramos, DiyaaElDin Ashour   +3 more
wiley   +1 more source

The gut microbiota: an emerging therapeutic target for ICI-associated myocarditis. [PDF]

Front Cell Infect Microbiol
Huang Z, Mei X, Zhou Y.
europepmc   +1 more source